After 2 years, SOLACI returns to Bolivia to continue promoting the development of interventional cardiology in Latin America. Do not hesitate to participate in this important event that will undoubtedly be enriching for medical practice and, also, to improve the quality of life of patients in our region. Are you planning on participating in the<a href="https://solaci.org/en/2019/08/14/all-you-need-to-know-about-bolivia-sessions-2019/" title="Read more" >...</a>
Celebrating 10 Years of ProEducar Fellow Course with Record Attendance
This year SOLACI celebrated the 10th issue of ProEducar Fellow Course during SOLACI-SBHCI 2019 in Sao Paulo. The course was a roaring success: not only did we have record attendance, with 150 attending fellows, but we also benefited from the participation of notorious international interventionists ─ among others, doctors Stone, Grines, Granada, Hijazi, Abizaid, Mendiz,<a href="https://solaci.org/en/2019/08/13/celebrating-10-years-of-proeducar-fellow-course-with-record-attendance/" title="Read more" >...</a>
ProEducar 2019 | We celebrate 10 Years of continuous interventional education!
The ProEducar Fellow Course is a special event designed for fellows or interventional trainees seeking to update their knowledge and perfect their skills on interventional cardiology. This intensive and quality event introduces four interventional modules focused on practice rather than theory, with step-by-step demonstrations, tips and secrets of the trade, and educational cases. The course<a href="https://solaci.org/en/2019/07/21/proeducar-2019-we-celebrate-10-years-of-continuous-interventional-education/" title="Read more" >...</a>
Many Guidelines, Much Confusion. Blood Pressure Targets in the Elderly
Seeing as hypertension prevalence and incidence increases with age, treating elderly patients of paramount importance. The AHA/ACC guidelines have lowered cohort hypertension thresholds to >130/80 mmHg, whereas the European guidelines have kept the classic >140/90 mmHg, though recommending lower thresholds for most patients at the same time. Lower than 130/80 mmHg is recommended with the<a href="https://solaci.org/en/2019/07/19/many-guidelines-much-confusion-blood-pressure-targets-in-the-elderly/" title="Read more" >...</a>
2019 Bolivia Sessions | Discover the Scientific Program
A most valuable event organized by SOLACI and the Bolivian Society of Cardiology (SOBOCAR) for all Latin American interventional cardiologists is almost upon us. The Bolivia Sessions will be held in Cochabamba, Bolivia, on August 23rd and 24th, 2019. This event will feature over 20 Latin American special guests and modules on: Acute coronary syndrome.<a href="https://solaci.org/en/2019/07/18/2019-bolivia-sessions-discover-the-scientific-program/" title="Read more" >...</a>
SOLACI-SBHCI 2019 Congress | International Joint Sessions
Prestigious Scientific Societies from all over the world will attend the Congress to discuss the latest advances in interventional cardiology. Discover the International Joint Sessions 01/08 | Paulista Room | 8:30 – 10:00 | Portuguese Society of Cardiology (APIC) Symposium – Acute Coronary Syndrome 8:30 – 8:42 – PCI in NSTEMI ACS: how and when<a href="https://solaci.org/en/2019/07/17/solaci-sbhci-2019-congress-international-joint-sessions/" title="Read more" >...</a>
New Promising Alternatives for Mitral Regurgitation
PASCAL transcatheter valve repair system for mitral regurgitation has shown feasibility and safety to treat patients with grade 3+ or 4+, regardless etiology. Regurgitation grade was significantly reduced, and this was accompanied by clinical improvement in functional class, exercise capacity and quality of life. This study soon to be published in J Am Coll Cardiol<a href="https://solaci.org/en/2019/07/15/new-promising-alternatives-for-mitral-regurgitation/" title="Read more" >...</a>
Next-Day Discharge after TAVR: Equally Safe for All Prosthesis?
Yet scarce, there is evidence supporting next-day discharge (NDD) after TAVR is safe when patients receiving balloon expandable valves meet certain conditions. This had not yet been shown for self-expandable valves. This study looks into NDD after TAVR by femoral access with self-expandable valves. The authors retrospectively compared all consecutive patients undergoing elective minimalist TAVR<a href="https://solaci.org/en/2019/07/04/next-day-discharge-after-tavr-equally-safe-for-all-prosthesis/" title="Read more" >...</a>
The Most Read Articles in Interventional Cardiology in SOLACI
1- What to Do with Blood Pressure Levels Between 130/80 and 139/89 mmHg The decision to be made with a treatment-free patient with systolic blood pressure over 160 mmHg or diastolic blood pressure over 100 mmHg is an easy one. All guidelines agree: treatment should be started immediately alongside lifestyle changes. Read also HERE 2- Low-Risk<a href="https://solaci.org/en/2019/07/02/the-most-read-articles-in-interventional-cardiology-in-solaci/" title="Read more" >...</a>
What Happens When We Are Blinded by Left Main Disease and Ignore All Other Lesions?
According to this recent Excel analysis, mortality seems to rise when the SYNTAX II score is not taken into account when defining the revascularization strategy. The difference does not reach statistical significance and further studies are required, but the message is clear: the left main coronary artery is not the only thing that matters; other<a href="https://solaci.org/en/2019/06/24/what-happens-when-we-are-blinded-by-left-main-disease-and-ignore-all-other-lesions/" title="Read more" >...</a>